Covered recipient · General Payments record
JULIUS K ADEBISI
General Payments · PY2018–2024
$2,019.69
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $740.45 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $477.71 | 23 |
| Bayer HealthCare Pharmaceuticals Inc. | $76.70 | 3 |
| Acerta Pharma LLC | $47.44 | 3 |
| Novo Nordisk AS | $40.25 | 2 |
| Otsuka America Pharmaceutical, Inc. | $39.21 | 2 |
| Amgen Inc. | $31.54 | 2 |
| Lilly USA, LLC | $13.88 | 1 |
| DEXCOM, INC. | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.42 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175462 | CMS |
| ABBVIE INC. | $11.90 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175464 | CMS |
| ABBVIE INC. | $16.22 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175466 | CMS |
| ABBVIE INC. | $17.37 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175468 | CMS |
| ABBVIE INC. | $17.82 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175470 | CMS |
| ABBVIE INC. | $27.53 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175472 | CMS |
| ABBVIE INC. | $10.45 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175474 | CMS |
| ABBVIE INC. | $24.03 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175476 | CMS |
| ABBVIE INC. | $18.54 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175478 | CMS |
| ABBVIE INC. | $13.74 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175480 | CMS |
| ABBVIE INC. | $27.56 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175482 | CMS |
| ABBVIE INC. | $26.69 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175484 | CMS |
| ABBVIE INC. | $24.91 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175486 | CMS |
| ABBVIE INC. | $20.91 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175488 | CMS |
| ABBVIE INC. | $22.70 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175490 | CMS |
| ABBVIE INC. | $28.59 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175492 | CMS |
| ABBVIE INC. | $24.81 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175494 | CMS |
| ABBVIE INC. | $19.41 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175496 | CMS |
| ABBVIE INC. | $20.21 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175498 | CMS |
| ABBVIE INC. | $19.21 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175500 | CMS |
| ABBVIE INC. | $17.81 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175502 | CMS |
| ABBVIE INC. | $28.99 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175504 | CMS |
| ABBVIE INC. | $23.89 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103175506 | CMS |
| Amgen Inc. | $15.97 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117184920 | CMS |
| Amgen Inc. | $15.57 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117184922 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.33 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104353554 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.06 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105567570 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.05 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105837035 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $23.78 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086249692 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $30.00 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086118428 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $22.92 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086252348 | CMS |
| Dexcom, Inc. | $13.72 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153312358 | CMS |
| Lilly USA, LLC | $13.88 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135114730 | CMS |
| Novo Nordisk Inc | $23.13 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096937407 | CMS |
| Novo Nordisk Inc | $17.12 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930808 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.53 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118848114 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.68 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118848116 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.